Post-stilbestrol secondary syndrome.
D000230:Adenocarcinoma / Q000139:chemically induced / Q000473:pathology; D000293:Adolescent; D000328:Adult; D004054:Diethylstilbestrol / Q000009:adverse effects*; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000139:chemically induced / Q000473:pathology; D011247:Pregnancy; D013577:Syndrome; D002577:Uterine Cervical Diseases / Q000139:chemically induced / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced / Q000473:pathology; D014621:Vagina / Q000473:pathology; D014623:Vaginal Diseases / Q000138:chemical synthesis* / Q000473:pathology; D014625:Vaginal Neoplasms / Q000139:chemically induced* / Q000473:pathology
D004054:Diethylstilbestrol